Osmanağaoğlu Mehmet A, Unal Sevilay, Bozkaya Hasan
Department of Obstetrics and Gynecology, School of Medicine, Karadeniz Technical University, 61080 Trabzon, Turkey.
Arch Gynecol Obstet. 2005 Jan;271(1):33-9. doi: 10.1007/s00404-004-0644-8. Epub 2004 Jun 5.
The objective of this study was to compare the neonatal outcome in patients with preterm premature rupture of membranes with and without clinical chorioamnionitis.
This is a retrospective study that included 254 pregnant women with preterm rupture of membranes. The study group was divided according to the presence or absence of clinical chorioamnionitis defined as the presence of two or more of the following criteria: maternal temperature >38 degrees C on two or more occasions > or =1 h apart, maternal tachycardia (> or =120 beats/min), uterine tenderness, foul smelling amniotic fluid, maternal leukocytosis > or =20,000 mm(-3) with bands and positive C reactive protein. Also the study population was divided according to the use of tocolysis. Exclusion criteria included multiple pregnancy, fetal congenital anomalies, diabetes mellitus and severe preeclampsia. Amniotic fluid was collected from the cervix or from the transabdominal amniocentesis. Antibiotics and tocolysis were used according to the hospital protocols. Parametric and nonparametric statistics were used for comparisons.
There were no significant differences in birth weight, Apgar scores at 1 and 5 min, rates of respiratory distress syndrome, intraventricular hemorrhage and necrotizing enterocolitis between patients with and without clinical chorioamnionitis or between women who received tocolysis and the ones that did not receive tocolysis. In cases of clinical chorioamnionitis and when tocolysis was used the neonates stayed longer in the neonatal intensive care unit (NICU).
Patients with preterm premature rupture of membranes and clinical chorioamnionitis have similar neonatal outcomes than the ones without clinical chorioamnionitis.
本研究的目的是比较有临床绒毛膜羊膜炎和无临床绒毛膜羊膜炎的胎膜早破患者的新生儿结局。
这是一项回顾性研究,纳入了254例胎膜早破的孕妇。研究组根据是否存在临床绒毛膜羊膜炎进行划分,临床绒毛膜羊膜炎定义为存在以下两项或更多标准:产妇体温在两次或更多次≥1小时间隔时>38摄氏度、产妇心动过速(≥120次/分钟)、子宫压痛、羊水有异味、产妇白细胞增多≥20,000/mm³ 伴杆状核细胞且C反应蛋白阳性。此外,研究人群还根据是否使用宫缩抑制剂进行划分。排除标准包括多胎妊娠、胎儿先天性异常、糖尿病和重度子痫前期。羊水从宫颈或经腹羊膜腔穿刺采集。抗生素和宫缩抑制剂的使用遵循医院方案。采用参数统计和非参数统计进行比较。
有临床绒毛膜羊膜炎和无临床绒毛膜羊膜炎的患者之间,以及接受宫缩抑制剂治疗和未接受宫缩抑制剂治疗的女性之间,出生体重、1分钟和5分钟时的阿氏评分、呼吸窘迫综合征发生率、脑室内出血和坏死性小肠结肠炎发生率均无显著差异。在临床绒毛膜羊膜炎且使用宫缩抑制剂的情况下,新生儿在新生儿重症监护病房(NICU)的住院时间更长。
胎膜早破且有临床绒毛膜羊膜炎的患者与无临床绒毛膜羊膜炎的患者具有相似的新生儿结局。